Sort
64,565 grants matching “drug discovery”
Discovery of novel lead-target pairs and identification of all-oral bactericidal drug regimens for Mycobacterium abscessus lung disease
$872,777Thomas Dick · Hackensack University Medical Center · R01 · FY2025 · AI
Activate Silent and Cryptic Intact Fungal SM Gene Clusters through FACs for Novel Antibiotics Discovery
$872,771Chengcang Charles Wu · Intact Genomics, Inc. · R44 · FY2017 · AI
Genomic characterization and development of therapies for pediatric sarcoma
$872,696John Shern · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA
Targeting a Novel Regulator of Brain Aging and Alzheimer's Disease
$872,459Bruce A Yankner · Harvard Medical School · R01 · FY2015 · AG
IGF::OT::IGFIn Vivo Metabolite Identification Study
$872,352Rose Hood · Sri International · N01 · FY2013 · DA
Group II mGluR antagonists and negative modulators in depression
$872,101Athina Markou · University Of California, San Diego · R01 · FY2012 · MH
Drug Repurposing Screening for Zika Virus Infection
$872,090Wei Zheng · National Center For Advancing Translational Sciences · ZIA · FY2018 · TR
Cell-free assay technologies for the identification of active compounds
$872,042Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2015 · CA
EBV NUCLEAR PROTEINS IN B CELL GROWTH TRANSFORMATION
$871,854Elliott D Kieff · Brigham And Women'S Hospital · R01 · FY2006 · CA
Novel Adjuvant Discovery in Vaccine Therapy
$871,728Jason S Lewis · Sloan-Kettering Inst Can Research · R01 · FY2012 · AI
Center for Interventional Oncology
$871,672Bradford J Wood · Division Of Basic Sciences - Nci · ZID · FY2020 · CA
Discovery of Molecules to disrupt the outer membrane of Gram-negative pathogens
$871,618Daniel E Kahne · Harvard Medical School · U19 · FY2014 · AI
Development of a metabolomics and machine learning based high-throughput screening platform for data-driven drug discovery
$871,587Aarash Bordbar · Sinopia Biosciences, Inc. · R44 · FY2022 · GM
A systems analysis of drug tolerance in Mycobacterium tuberculosis
$871,572Nitin S Baliga · Institute For Systems Biology · R01 · FY2017 · AI
Identifying driver mutations and tumor dependencies by comparative oncogenomics.
$871,519Scott W Lowe · Cold Spring Harbor Laboratory · U01 · FY2010 · CA
2/7 Psychiatric Genomics Consortium: Finding Actionable Variation
$871,340Mark J Daly · Massachusetts General Hospital · U01 · FY2019 · MH
Vascular Immunobiology Mechanistic and Translational Studies
$871,079Yogen Kanthi · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Targeting regulators of cellular gene transcription to impact HIV latency
$870,956Douglas D Richman · Veterans Medical Research Fdn/San Diego · P01 · FY2010 · AI
DNA HELICASE AND PRIMASE INHIBITORS FOR BIODEFENSE
$870,838Donald T Moir · Microbiotix, Inc · R42 · FY2009 · AI
Cellular and Molecular Control of Normal and Disordered Erythropoiesis
$870,543Lionel Blanc · Feinstein Institute For Medical Research · R35 · FY2025 · HL
Cellular and Molecular Control of Normal and Disordered Erythropoiesis
$870,543Lionel Blanc · Feinstein Institute For Medical Research · R35 · FY2024 · HL
Multicenter Interventional Lymphangioleiomyomatosis Early Disease Trial (MILED)-CCC
$870,308Francis X McCormack · University Of Cincinnati · U01 · FY2018 · HL
Inhibitors of poxvirus enzymes as novel drugs
$870,266Esteban Edward Mena · Lifepharms, Inc. · U01 · FY2008 · AI
Signal Transduction Events and the Regulation of Cell Growth
$870,159Jane B Trepel · Division Of Clinical Sciences - Nci · ZIC · FY2016 · CA
Functions and Activities of p53 and Mdm2 in Normal and Cancer Cells
$870,147Carol Prives · Columbia Univ New York Morningside · R35 · FY2021 · CA